Bristol-Myers Subpoenaed Over Plavix Deal

Law360 (April 3, 2007, 12:00 AM EDT) -- U.S. antitrust regulators have sent a subpoena to Bristol-Myers Squibb Co. seeking information about a deal the drug maker made with generics rival Apotex Inc. to delay competition for its popular blood-thinner Plavix.

The request for information from the U.S. Federal Trade Commission was revealed on March 21 in Bristol-Myers Squibb’s annual regulatory filing with the U.S. Securities and Exchange Commission.

The New York-based company said in a statement that it plans to cooperate fully with the investigation. The deal at the center of the probe...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.